{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:55:54Z","timestamp":1793361354033,"version":"4.5.0"},"reference-count":109,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:p>Most sexually active youth in the United States do not believe that they are at risk for contracting HIV and have never been tested. Creating safe environments that promote confidentiality and respect, obtaining an accurate sexual and reproductive health assessment, and providing nonstigmatizing risk counseling are key components of any youth encounters. Pediatricians can play a key role in preventing and controlling HIV infection by promoting risk-reduction counseling and offering routine HIV testing and prophylaxis to adolescent and young adult (youth) patients. In light of persistently high numbers of people living with HIV in the United States and documented missed opportunities for HIV testing, the Centers for Disease Control and Prevention and the US Preventive Services Task Force recommend universal and routine HIV screening among US populations, including youth. Recent advances in HIV diagnostics, treatment, and prevention help support this recommendation. This clinical report reviews epidemiological data and recommends that routine HIV screening be offered to all youth 15 years or older, at least once, in health care settings. After initial screening, youth at increased risk, including those who are sexually active, should be rescreened at least annually, and potentially as frequently as every 3 to 6 months if at high risk (male youth reporting male sexual contact, active injection drug users, transgender youth; youth having sexual partners who are HIV-infected, of both genders, or injection drug users; youth exchanging sex for drugs or money; or youth who have had a diagnosis of or have requested testing for other sexually transmitted infections). Youth at substantial risk for HIV acquisition should be routinely offered HIV preexposure prophylaxis, and HIV postexposure prophylaxis is also indicated after high-risk exposures. This clinical report also addresses consent, confidentiality, and coverage issues that pediatricians face in promoting routine HIV testing and HIV prophylaxis for their patients.<\/jats:p>","DOI":"10.1542\/peds.2021-055207","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T08:13:35Z","timestamp":1639988015000},"source":"Crossref","is-referenced-by-count":36,"title":["Adolescents and Young Adults: The Pediatrician\u2019s Role in HIV Testing and Pre- and Postexposure HIV Prophylaxis"],"prefix":"10.1542","volume":"149","author":[{"given":"Katherine K","family":"Hsu","sequence":"first","affiliation":[{"name":"Division of STD Prevention and HIV\/AIDS Surveillance, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts"},{"name":"Section of Pediatric Infectious Diseases, Boston University Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natella Yurievna","family":"Rakhmanina","sequence":"additional","affiliation":[{"name":"Children\u2019s National Hospital, School of Medicine and Health Sciences, The George Washington University, Washington, DC"},{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"#cr-split#-2022020200134450200_B1.1","unstructured":"Centers for Disease Control and Prevention  . Estimated HIV incidence and prevalence in the United States, 2014-2018. HIV Surveillance Supplemental Report 2020"},{"key":"#cr-split#-2022020200134450200_B1.2","unstructured":"volume 25, No. 1. 2020. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance- supplemental-report-vol-25-1.pdf. Accessed August 3, 2020"},{"key":"2022020200134450200_B2","unstructured":"HIV Surveillance Report\n          , 2018 (Updated); vol. 31. 2020. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/68\/wr\/mm6811e1.htm. Accessed August 3, 2020"},{"issue":"11","key":"2022020200134450200_B3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15585\/mmwr.mm6811e1","article-title":"Vital Signs: HIV transmission along the continuum of care \u2014 United States, 2016","volume":"68","author":"Li","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"47","key":"2022020200134450200_B4","first-page":"1113","article-title":"Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011","volume":"63","author":"Bradley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"3","key":"2022020200134450200_B5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/apc.2013.0345","article-title":"The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities","volume":"28","author":"Zanoni","year":"2014","journal-title":"AIDS Patient Care STDS."},{"issue":"1","key":"2022020200134450200_B6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1542\/peds.107.1.188","article-title":"Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention","volume":"107","author":"American Academy of Pediatrics. Committee on Pediatric AIDS and Committee on Adolescence; Committee on Pediatric AIDS and Committee on Adolescence","year":"2001","journal-title":"Pediatrics."},{"issue":"5","key":"2022020200134450200_B7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1542\/peds.2011-1761","article-title":"Adolescents and HIV infection: the pediatrician\u2019s role in promoting routine testing","volume":"128","author":"Emmanuel","year":"2011","journal-title":"Pediatrics."},{"issue":"1","key":"2022020200134450200_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.su6901a1","article-title":"Overview and methods for the Youth Risk Behavior Surveillance \u2014 United States, 2019","volume":"69","author":"Underwood","year":"2020","journal-title":"MMWR Suppl."},{"key":"2022020200134450200_B9","unstructured":"Centers for Disease Control and Prevention\n          . HIV among transgender people. Available at: https:\/\/www.cdc.gov\/hiv\/group\/gender\/transgender\/index.html. Accessed August 4, 2020"},{"issue":"9","key":"2022020200134450200_B10","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1007\/s10461-016-1656-7","article-title":"Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009-2014","volume":"21","author":"Clark","year":"2017","journal-title":"AIDS Behav."},{"issue":"1","key":"2022020200134450200_B11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2018.304727","article-title":"Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017","volume":"109","author":"Becasen","year":"2019","journal-title":"Am J Public Health."},{"key":"2022020200134450200_B12","unstructured":"Kaiser Family Foundation\n          . National survey of young adults on HIV\/AIDS. Available at: https:\/\/www.kff.org\/hivaids\/report\/national-survey-of- young-adults-on-hiv-aids\/. Accessed August 4, 2020"},{"issue":"6","key":"2022020200134450200_B13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/apc.2006.0112","article-title":"Barriers and facilitators to adolescent HIV testing","volume":"21","author":"Peralta","year":"2007","journal-title":"AIDS Patient Care STDS."},{"key":"2022020200134450200_B14","doi-asserted-by":"crossref","unstructured":"Henry-Reid\u2008LM, O\u2019Connor\u2008KG, Klein\u2008JD, Cooper\u2008E, Flynn\u2008P, Futterman\u2008DC. Current pediatrician practices in identifying high-risk behaviors of adolescents. Pediatrics.2010;125(4). Available at: www.pediatrics.org\/cgi\/content\/full\/125\/4\/e741","DOI":"10.1542\/peds.2009-0271"},{"issue":"2","key":"2022020200134450200_B15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jpeds.2014.04.009","article-title":"Clinician adherence to recommendations for screening of adolescents for sexual activity and sexually transmitted infection\/human immunodeficiency virus","volume":"165","author":"Goyal","year":"2014","journal-title":"J Pediatr."},{"issue":"RR-14","key":"2022020200134450200_B16","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep."},{"key":"2022020200134450200_B17","unstructured":"US Preventive Services Task Force\n          . Final Recommendation statement: human immunodeficiency virus (HIV) infection: screening. 2019. Available at: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/human- immunodeficiency-virus-hiv-infection- screening. Accessed September 7, 2019"},{"key":"2022020200134450200_B18","unstructured":"Department of Health and Human Services\u2019 Office of HIV\/AIDS and Infectious Disease Policy\n          . National HIV\/AIDS Strategy for the United States: 2017 Progress Report. Available at: https:\/\/files.hiv.gov\/s3fs-public\/NHAS_Progress_Report_2017.pdf. Accessed April 4, 2019"},{"key":"2022020200134450200_B19","unstructured":"Centers for Disease Control and Prevention\n          . US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 Update: a clinical practice guideline. 2018. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf. Accessed October 5, 2018"},{"key":"2022020200134450200_B20","unstructured":"US Preventive Services Task Force\n          . Final recommendation statement: prevention of human immunodeficiency virus (HIV) infection: preexposure prophylaxis. 2019. Available at: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/ prevention-of-human-immunodeficiency- virus-hiv-infection-pre-exposure- prophylaxis?ds=1&s=HIV. Accessed June 26, 2019"},{"issue":"3","key":"2022020200134450200_B21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jadohealth.2015.12.009","article-title":"Confidentiality protections for adolescents and young adults in the health care billing and insurance claims process","volume":"58","author":"Society for Adolescent Health and Medicine; American Academy of Pediatrics","year":"2016","journal-title":"J Adolesc Health."},{"issue":"5","key":"2022020200134450200_B22","doi-asserted-by":"crossref","first-page":"e20172858","DOI":"10.1542\/peds.2017-2858","article-title":"Sexual and reproductive health care services in the pediatric setting","volume":"140","author":"Marcell","year":"2017","journal-title":"Pediatrics."},{"issue":"6","key":"2022020200134450200_B23","doi-asserted-by":"crossref","first-page":"e20172858","DOI":"10.1542\/peds.2018-2998","article-title":"Targeted reforms in health care financing to improve the care of adolescents and young adults","volume":"142","author":"Marcell","year":"2018","journal-title":"Pediatrics."},{"key":"2022020200134450200_B24","unstructured":"American Academy of Pediatrics\n          . Bright Futures: adolescence tools. Available at: https:\/\/brightfutures.aap.org\/materials-and-tools\/tool-and- resource-kit\/Pages\/adolescence-tools.aspx. Accessed October 5, 2018"},{"issue":"2","key":"2022020200134450200_B25","doi-asserted-by":"crossref","first-page":"e20161347","DOI":"10.1542\/peds.2016-1347","article-title":"Achieving quality health services for adolescents","volume":"138","author":"Committee on Adolescence","year":"2016","journal-title":"Pediatrics."},{"issue":"2","key":"2022020200134450200_B26","doi-asserted-by":"crossref","first-page":"e20181403","DOI":"10.1542\/peds.2018-1403","article-title":"Discussion of potentially sensitive topics with young people","volume":"143","author":"Santelli","year":"2019","journal-title":"Pediatrics."},{"key":"2022020200134450200_B27","doi-asserted-by":"crossref","DOI":"10.1542\/9781610020237","volume-title":"Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents","author":"Hagan","year":"2017","edition":"4th ed."},{"issue":"2","key":"2022020200134450200_B28","doi-asserted-by":"crossref","first-page":"e20161348","DOI":"10.1542\/peds.2016-1348","article-title":"Sexuality Education for Children and Adolescents","volume":"138","author":"Breuner","year":"2016","journal-title":"Pediatrics."},{"key":"2022020200134450200_B29","unstructured":"US Preventive Services Task Force\n          . Final recommendation statement: sexually transmitted infections: behavioral counseling. 2016. Available at: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/Recommendation StatementFinal\/sexually-transmitted- infections-behavioral-counseling. Accessed October 5, 2018"},{"issue":"5 Pt 1","key":"2022020200134450200_B30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1542\/peds.111.5.996","article-title":"Missed opportunities for sexually transmitted diseases, human immunodeficiency virus, and pregnancy prevention services during adolescent health supervision visits","volume":"111","author":"Burstein","year":"2003","journal-title":"Pediatrics."},{"issue":"4","key":"2022020200134450200_B31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jadohealth.2006.04.007","article-title":"Vaccination: an opportunity to enhance early adolescent preventative services","volume":"39","author":"Rupp","year":"2006","journal-title":"J Adolesc Health."},{"key":"2022020200134450200_B32","volume-title":"PPE: Pre-Participation Physical Evaluation","author":"Bernhardt","year":"2019","edition":"5th ed."},{"key":"2022020200134450200_B33","article-title":"Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations","author":"Branson","year":"2014"},{"issue":"3","key":"2022020200134450200_B34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15585\/mmwr.mm6903a2","article-title":"Trends in HIV-2 diagnoses and use of the HIV-1\/HIV-2 differentiation test \u2013 United States, 2010-2017","volume":"69","author":"Peruski","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2022020200134450200_B35","unstructured":"Centers for Disease Control and Prevention and Association of Public Health Laboratories\n          . 2018 Quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens. 2018. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/50872. Accessed October 8, 2018"},{"issue":"17","key":"2022020200134450200_B36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/archinte.163.17.2097","article-title":"Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings","volume":"163","author":"Weintrob","year":"2003","journal-title":"Arch Intern Med."},{"issue":"6","key":"2022020200134450200_B37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10461-008-9519-5","article-title":"Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North Carolina","volume":"13","author":"Hightow-Weidman","year":"2009","journal-title":"AIDS Behav."},{"issue":"1","key":"2022020200134450200_B38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/aid.2012.0064","article-title":"Acute HIV-1 infection in the Southeastern United States: a cohort study","volume":"29","author":"McKellar","year":"2013","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"22","key":"2022020200134450200_B39","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective study of acute HIV-1 infection in adults in east Africa and Thailand","volume":"374","author":"Robb","year":"2016","journal-title":"N Engl J Med."},{"key":"2022020200134450200_B40","unstructured":"Emory University, Rollins School of Public Health\n          . AIDSVu. Available at: https:\/\/aidsvu.org\/. Accessed February 28, 2019"},{"key":"2022020200134450200_B41","unstructured":"Centers for Disease Control and Prevention\n          . NCHHSTP AtlasPlus. 2017. Available at: https:\/\/www.cdc.gov\/nchhstp\/atlas\/index.htm. Accessed October 8, 2018"},{"key":"2022020200134450200_B42","unstructured":"Centers for Disease Control and Prevention\n          . Advantages and disadvantages of FDA-approved HIV assays used for screening. 2018. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/testing\/hiv-tests-advantages- disadvantages_1.pdf. Accessed October 8, 2018"},{"key":"2022020200134450200_B43","unstructured":"Centers for Disease Control and Prevention\n          . Rapid HIV tests suitable for use in clinical settings (CLIA-moderate complexity). 2016. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/testing\/rapid- hiv-tests-clinical-moderate-complexity.pdf. Accessed October 8, 2018"},{"key":"2022020200134450200_B44","unstructured":"Centers for Disease Control and Prevention\n          . Rapid HIV tests suitable for use in non-clinical settings (CLIA-waived). 2018. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/testing\/rapid-hiv-tests-non-clinical.pdf. Accessed October 8, 2018"},{"key":"2022020200134450200_B45","unstructured":"US Food and Drug Administration\n          . Facts about in-home HIV testing. 2017. Available at: https:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm310545.htm. Accessed April 7, 2019"},{"issue":"11","key":"2022020200134450200_B46","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10461-015-1097-8","article-title":"Attitudes and acceptability on HIV self-testing among key populations: a literature review","volume":"19","author":"Figueroa","year":"2015","journal-title":"AIDS Behav."},{"key":"2022020200134450200_B47","article-title":"Awareness and acceptance of HIV self-testing and PrEP among adolescents, young adults and their caregivers in Washington, DC, USA","author":"Barksdale"},{"key":"2022020200134450200_B48","unstructured":"Centers for Disease Control and Prevention\n          . Understanding a positive result. Available at: www.cdc.gov\/hiv\/basics\/hiv-testing\/positive-hiv-results.html. Accessed September 16, 2020"},{"key":"2022020200134450200_B49","unstructured":"Office of AIDS Research, National Institutes of Health\n          . How to find HIV treatment services. 2020. Available at: https:\/\/hivinfo.nih.gov\/understanding- hiv\/fact-sheets\/how-find-hiv-treatment- services. Accessed September 21, 2019"},{"issue":"10","key":"2022020200134450200_B50","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archinte.165.10.1133","article-title":"Physician specialization and the quality of care for human immunodeficiency virus infection","volume":"165","author":"Landon","year":"2005","journal-title":"Arch Intern Med."},{"issue":"9","key":"2022020200134450200_B51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/apc.2016.0170","article-title":"Quality of care for HIV\/AIDS and for primary prevention by HIV specialists and nonspecialists","volume":"30","author":"Landovitz","year":"2016","journal-title":"AIDS Patient Care STDS."},{"issue":"10","key":"2022020200134450200_B52","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2105\/AJPH.2018.304561","article-title":"HIV preexposure prophylaxis as a gateway to primary care","volume":"108","author":"Marcus","year":"2018","journal-title":"Am J Public Health."},{"key":"2022020200134450200_B53","unstructured":"Centers for Disease Control and Prevention\n          . Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV\u2014 United States, 2016. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/programresources\/cdc-hiv-npep-guidelines.pdf. Accessed September 7, 2020"},{"key":"2022020200134450200_B54","unstructured":"Centers for Disease Control and Prevention\n          . Technical update: use of the determine HIV 1\/2 Ag\/Ab combo test with serum or plasma in the laboratory algorithm for HIV diagnosis. 2017. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/48472. Accessed February 28, 2019"},{"key":"2022020200134450200_B55","unstructured":"Centers for Disease Control and Prevention\n          . Technical update on HIV-1\/2 Differentiation assays. 2016. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/40790. Accessed February 28, 2019"},{"key":"2022020200134450200_B56","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents\n          . Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Available at: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/AdultandAdolescentGL.pdf. Accessed October 8, 2018"},{"key":"2022020200134450200_B57","unstructured":"Centers for Disease Control and Prevention\n          . State laws that address high-impact HIV prevention efforts. 2018. Available at: https:\/\/www.cdc.gov\/hiv\/policies\/law\/states\/index.html. Accessed May 29, 2019"},{"key":"2022020200134450200_B58","unstructured":"Centers for Disease Control and Prevention\n          . State laws that enable a minor to provide informed consent to receive hiv and std services. Available at https:\/\/www.cdc.gov\/hiv\/policies\/law\/states\/minors.html. Accessed February 28, 2019"},{"issue":"6","key":"2022020200134450200_B59","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jamapediatrics.2017.0105","article-title":"Evaluating testing strategies for identifying youths with HIV infection and linking youths to biomedical and other prevention services","volume":"171","author":"Miller","year":"2017","journal-title":"JAMA Pediatr."},{"issue":"1","key":"2022020200134450200_B60","first-page":"1","article-title":"Births: final data for 2015","volume":"66","author":"Martin","year":"2017","journal-title":"Natl Vital Stat Rep."},{"issue":"6","key":"2022020200134450200_B61","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States--an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med."},{"key":"2022020200134450200_B62","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/522546","article-title":"Cost-effectiveness of HIV testing and treatment in the United States","volume":"45","author":"Walensky","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"6","key":"2022020200134450200_B63","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMsa042657","article-title":"Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy","volume":"352","author":"Sanders","year":"2005","journal-title":"N Engl J Med."},{"issue":"1","key":"2022020200134450200_B64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jadohealth.2017.08.028","article-title":"The optimal age for screening adolescents and young adults without identified risk factors for HIV","volume":"62","author":"Neilan","year":"2018","journal-title":"J Adolesc Health."},{"issue":"1","key":"2022020200134450200_B65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jadohealth.2017.09.003","article-title":"In search of the right time and right place: screening adolescents and youth for human immunodeficiency virus in the United States","volume":"62","author":"Rakhmanina","year":"2018","journal-title":"J Adolesc Health."},{"key":"2022020200134450200_B66","doi-asserted-by":"crossref","unstructured":"Grant\u2008AM, Jamieson\u2008DJ, Elam-Evans\u2008LD, Beck-Sague\u2008C, Duerr\u2008A, Henderson\u2008SL. Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection. Pediatrics.2006;117(3). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/3\/e468","DOI":"10.1542\/peds.2005-0142"},{"issue":"9","key":"2022020200134450200_B67","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2105\/AJPH.89.9.1397","article-title":"Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997","volume":"89","author":"Weinhardt","year":"1999","journal-title":"Am J Public Health."},{"key":"2022020200134450200_B68","unstructured":"Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV\n          . Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/PedARV_GL.pdf. Accessed October 23, 2018"},{"key":"2022020200134450200_B69","doi-asserted-by":"crossref","unstructured":"Murphy\u2008DA, Mitchell\u2008R, Vermund\u2008SH, Futterman\u2008D, Adolescent Medicine\u2008H; Adolescent Medicine HIV\/AIDS Research Network. Factors associated with HIV testing among HIV-positive and HIV- negative high-risk adolescents: the REACH Study. Reaching for Excellence in Adolescent Care and Health. Pediatrics.2002;110(3). Available at: www.pediatrics.org\/cgi\/content\/full\/110\/3\/e36","DOI":"10.1542\/peds.110.3.e36"},{"issue":"2","key":"2022020200134450200_B70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/QAI.0000000000000958","article-title":"HIV testing, care referral, and linkage to care intervals affect time to engagement in care for newly diagnosed HIV-infected adolescents in 15 adolescent medicine clinics in the United States","volume":"72","author":"Philbin","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"8","key":"2022020200134450200_B71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpedi.161.8.777","article-title":"Chlamydial screening in urgent care visits: adolescent-reported acceptability associated with adolescent perception of clinician communication","volume":"161","author":"Miller","year":"2007","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"47","key":"2022020200134450200_B72","first-page":"1269","article-title":"Missed opportunities for earlier diagnosis of HIV infection--South Carolina, 1997-2005","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"4","key":"2022020200134450200_B73","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1542\/peds.2009-0237","article-title":"Implementation of and barriers to routine HIV screening for adolescents","volume":"124","author":"Minniear","year":"2009","journal-title":"Pediatrics."},{"issue":"2","key":"2022020200134450200_B74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jadohealth.2013.07.027","article-title":"Factors affecting acceptance of routine human immunodeficiency virus screening by adolescents in pediatric emergency departments","volume":"54","author":"Rakhmanina","year":"2014","journal-title":"J Adolesc Health."},{"issue":"1","key":"2022020200134450200_B75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV preexposure prophylaxis demonstration project and safety study for young MSM","volume":"74","author":"Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"11","key":"2022020200134450200_B76","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","article-title":"Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States","volume":"171","author":"Hosek","year":"2017","journal-title":"JAMA Pediatr."},{"key":"2022020200134450200_B77","unstructured":"Food and Drug Administration\n          . Highlights of prescribing information: TRUVADA (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021752s055lbl.pdf. Accessed October 5, 2018"},{"key":"2022020200134450200_B78","unstructured":"Food and Drug Administration\n          . Highlights of prescribing information: DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/208215s011lbl.pdf. Accessed September 14, 2020"},{"key":"2022020200134450200_B79","unstructured":"US Food and Drug Administration\n          . FDA Briefing Document: Meeting of the Antimicrobial Drugs Advisory Committee.Silver Spring, MD: US Food and Drug Administration; 2019. Available at: https:\/\/www.fda.gov\/media\/129607\/download. Accessed September 14, 2020"},{"issue":"3","key":"2022020200134450200_B80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6903a1","article-title":"Preexposure prophylaxis for prevention of HIV acquisition among adolescents: Clinical considerations, 2020","volume":"69","author":"Tanner","year":"2020","journal-title":"MMWR Recomm Rep."},{"issue":"112","key":"2022020200134450200_B81","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med."},{"issue":"4","key":"2022020200134450200_B82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MOP.0000000000000512","article-title":"HIV preexposure prophylaxis for adolescents and young adults","volume":"29","author":"Allen","year":"2017","journal-title":"Curr Opin Pediatr."},{"issue":"12","key":"2022020200134450200_B83","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol."},{"issue":"43","key":"2022020200134450200_B84","doi-asserted-by":"crossref","first-page":"e17716","DOI":"10.1097\/MD.0000000000017716","article-title":"Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings","volume":"98","author":"Ajayi","year":"2019","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"2022020200134450200_B85","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jadohealth.2018.06.023","article-title":"Knowledge and attitudes about pre-exposure prophylaxis among young adults experiencing homelessness in seven U.S. cities","volume":"64","author":"Santa Maria","year":"2019","journal-title":"J Adolesc Health."},{"issue":"4","key":"2022020200134450200_B86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/INF.0000000000003029","article-title":"Awareness of and attitudes toward pre-exposure prophylaxis among predominantly heterosexual black adolescents and young adults and their guardians in an urban area with HIV epidemic in the United States","volume":"40","author":"Koay","year":"2021","journal-title":"Pediatr Infect Dis J."},{"issue":"7","key":"2022020200134450200_B87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/apc.2016.0048","article-title":"Adolescent human immunodeficiency virus care providers\u2019 attitudes toward the use of oral pre-exposure prophylaxis in youth","volume":"30","author":"Mullins","year":"2016","journal-title":"AIDS Patient Care STDS."},{"issue":"12","key":"2022020200134450200_B88","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1089\/apc.2017.0147","article-title":"HIV care providers\u2019 intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults","volume":"31","author":"Mullins","year":"2017","journal-title":"AIDS Patient Care STDS."},{"issue":"6","key":"2022020200134450200_B89","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40265-019-01108-x","article-title":"Drug resistance during HIV pre-exposure prophylaxis","volume":"79","author":"Gibas","year":"2019","journal-title":"Drugs."},{"issue":"9","key":"2022020200134450200_B90","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s10461-014-0839-3","article-title":"HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study","volume":"18","author":"Krakower","year":"2014","journal-title":"AIDS Behav."},{"issue":"12","key":"2022020200134450200_B91","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamapediatrics.2020.2545","article-title":"Normalization of preexposure prophylaxis for adolescents: empowerment, not vulnerability","volume":"174","author":"Saleska","year":"2020","journal-title":"JAMA Pediatr."},{"key":"2022020200134450200_B92","unstructured":"Centers for Disease Control and Prevention\n          . Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV\u2014United States, 2016. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/programresources\/cdc-hiv-npep- guidelines.pdf. Accessed October 5, 2018"},{"issue":"9","key":"2022020200134450200_B93","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis","volume":"34","author":"Kuhar","year":"2013","journal-title":"Infect Control Hosp Epidemiol."},{"issue":"3","key":"2022020200134450200_B94","doi-asserted-by":"crossref","first-page":"e20164243","DOI":"10.1542\/peds.2016-4243","article-title":"Care of the adolescent after an acute sexual assault","volume":"139","author":"Crawford-Jakubiak","year":"2017","journal-title":"Pediatrics."},{"key":"2022020200134450200_B95","doi-asserted-by":"crossref","unstructured":"Workowski\u2008KA, Bachmann\u2008LH, Chan\u2008PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021: Sexual Assault and Abuse and STIs. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/rr7004a1.htm#sexualassaultandabuseandstis. Accessed November 28, 2021","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"2022020200134450200_B96","unstructured":"Child Welfare Information Gateway\n          . State statutes: searchable online database. Available at: https:\/\/www.childwelfare.gov\/topics\/systemwide\/laws-policies\/state\/. Accessed February 21, 2019"},{"issue":"3","key":"2022020200134450200_B97","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jadohealth.2006.09.015","article-title":"Forgone health care among U.S. adolescents: associations between risk characteristics and confidentiality concern","volume":"40","author":"Lehrer","year":"2007","journal-title":"J Adolesc Health."},{"issue":"2","key":"2022020200134450200_B98","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamapediatrics.2013.4338","article-title":"Sexuality talk during adolescent health maintenance visits","volume":"168","author":"Alexander","year":"2014","journal-title":"JAMA Pediatr."},{"key":"2022020200134450200_B99","unstructured":"Guttmacher Institute\n          . State Laws and Policies: Minors\u2019 access to STI services. Available at: www.guttmacher.org\/statecenter\/spibs\/spib_MASS.pdf. Accessed October 8, 2018"},{"key":"2022020200134450200_B100","volume-title":"State Minor Consent Laws: A Summary","author":"English","year":"2010","edition":"3rd ed."},{"key":"2022020200134450200_B101","unstructured":"Centers for Disease Control and Prevention\n          . HIV and STD criminal laws. Available at: https:\/\/www.cdc.gov\/hiv\/policies\/law\/states\/exposure.html. Accessed January 27, 2020"},{"key":"2022020200134450200_B102","unstructured":"Federal HIV Web Council\n          . Your legal rights: limits on confidentiality. Available at: https:\/\/www.hiv.gov\/hiv-basics\/living-well-with-hiv\/your-legal- rights\/limits-on-confidentiality. Accessed January 27, 2020"},{"key":"2022020200134450200_B103","unstructured":"Bradley\u2008T\n          . Legal Issues associated with disclosure of patient's HIV-positive status to third parties. TheBodyPro. Available at: www.thebody.com\/aahivm\/summer02\/disclosure.html. Accessed November 3, 2020"},{"issue":"1","key":"2022020200134450200_B104","doi-asserted-by":"crossref","first-page":"e20191359","DOI":"10.1542\/peds.2019-1359","article-title":"Electronic communication of the health record and information with pediatric patients and their guardians","volume":"144","author":"Webber","year":"2019","journal-title":"Pediatrics."},{"key":"2022020200134450200_B105","unstructured":"Centers for Disease Control and Prevention\n          . HIV\/AIDS preventive services. Available at: https:\/\/www.cdc.gov\/nchhstp\/preventionthroughhealthcare\/preventiveservices\/hivaids.htm. Accessed October 8, 2018"},{"key":"2022020200134450200_B106","unstructured":"US Department of Health and Human Services, Office of Population Affairs\n          . Title X grantees. Available at: https:\/\/www.hhs. gov\/opa\/title-x-family-planning\/title-x-grantees\/index.html. Accessed October 8, 2018"},{"key":"2022020200134450200_B107","unstructured":"Centers for Disease Control and Prevention\n          . GetTested: National HIV, STD, and hepatitis testing. Available at: https:\/\/gettested.cdc.gov. Accessed October 8, 2018"},{"key":"2022020200134450200_B108","unstructured":"Centers for Disease Control and Prevention\n          . Partner notification services. Available at: https:\/\/www.cdc.gov\/actagainstaids\/campaigns\/pic\/talks\/partner-notification.html. Accessed October 8, 2018"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-055207\/1256158\/peds_2021055207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-055207\/1256158\/peds_2021055207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:15:21Z","timestamp":1643760921000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/149\/1\/e2021055207\/183848\/Adolescents-and-Young-Adults-The-Pediatrician-s"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,20]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-055207","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"article-number":"e2021055207"}}